LOS ANGELES, May 9, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB:
MDBX) (www.medbox.com), announced today that its company
information would be made available via S&P Capital IQ
Corporation Records Listing Program. As part of the program,
a full description of Medbox, Inc., will be published in the Daily
News Section of Standard & Poors's Corporation Records, a
recognized securities manual for secondary trading in up to 38
States under the Blue Sky Laws. S&P Capital IQ
Corporation Records is available in print, CD-ROM, and via the web
at www.netadvantage.standardandpoors.com as well as through
numerous electronic vendors.
The company information about Medbox, Inc. to be made available
through this program includes an in-depth description of the
Medbox, Inc's. business operations, share price, dividend history,
shares outstanding, company financial position, earnings, and full
income statement and balance sheet.
Dr. Bruce Bedrick, CEO of Medbox, commented, "We are
proud to be part of the S&P Capital IQ program. We look
forward to our Company being much more visible to the
institutional investment community."
About Medbox,
Inc:
Medbox is a leader in the development, sales and service of
automated, biometrically controlled dispensing and storage systems
for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned
subsidiary, Medicine Dispensing Systems, offers their patented
systems, software and consulting services to pharmacies,
alternative medicine dispensaries and local governments in the U.S.
In addition, through its wholly owned subsidiary, Vaporfection
International, Inc. (www.vaporfection.com), the company offers an
industry award winning medical vaporizer product. Medbox, through
its newly established subsidiaries, also engages in the following
ancillary services catered to the alternative medicine industry:
merchant services and armored transport for cash deposits,
cannabidiol R&D, real estate acquisitions and subsequent lease
programs to alternative medicine dispensaries, and also alternative
medicine dispensary management services.
Medbox, Inc. is a publicly traded company, and is quoted on the
OTCQB, ticker symbol MDBX. For more information on Medbox,
please contact the company at (800) 762-1452 or go online to
www.medbox.com. For additional due diligence information,
visit: www.thedispensingsolution.com/investors
About S&P Capital IQ
S&P Capital IQ, a part of McGraw Hill Financial, is a
leading provider of multi-asset class and real time data, research
and analytics to institutional investors, investment and commercial
banks, investment advisors and wealth managers, corporations and
universities around the world. Evaluated pricing is prepared by
Standard & Poor's Securities Evaluations, Inc., a part of
S&P Capital IQ and a registered investment adviser with the
U.S. Securities and Exchange Commission. In the United
States, research reports are prepared by Standard & Poor's
Investment Advisory Services LLC, a part of S&P Capital IQ and
a registered investment adviser with the U.S. Securities and
Exchange Commission. S&P Capital IQ provides a broad suite of
capabilities designed to help track performance, generate alpha,
and identify new trading and investment ideas, and perform risk
analysis and mitigation strategies. Through leading desktop
solutions such as the S&P Capital IQ, Global Credit Portal and
MarketScope Advisor desktops; enterprise solutions such as S&P
Capital IQ Valuations; and research offerings, including Leveraged
Commentary & Data, Global Markets Intelligence, and company and
funds research, S&P Capital IQ sharpens financial intelligence
into the wisdom today's investors need. For more information visit:
www.spcapitaliq.com
Company information distributed through the Corporation Records
Program is based upon information that S&P Capital IQ considers
to be reliable, but neither S&P Capital IQ nor its affiliates
warrant its completeness or accuracy, and it should not be relied
upon as such. This material is not intended as an offer or
solicitation for the purchase or sale of any security or other
financial instrument.
Contacts:
Medbox, Inc.
Investor Relations
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@haydenir.com
S&P Capital IQ Customer Contact:
Soundia
O'Connor
212 438-4482
richard.albanese@spcapitaliq.com
S&P Capital IQ Media Relations
Contact:
Michael
Privitera
212 438-6679
michael.privitera@spcapitaliq.com
SOURCE Medbox, Inc.